{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:53:56Z","timestamp":1773125636542,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41417-018-0055-9","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T12:27:08Z","timestamp":1541075228000},"page":"174-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phase I trial of intravenous Ad5CRT in patients with liver metastasis of gastrointestinal cancers"],"prefix":"10.1038","volume":"26","author":[{"given":"Sang-Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Pil","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong-Cherl","family":"Kook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Hoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hark Kyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"key":"55_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40425-017-0277-7","volume":"5","author":"R Garcia-Carbonero","year":"2017","unstructured":"Garcia-Carbonero R, Salazar R, Duran I, Osman-Garcia I, Paz-Ares L, Bozada JM, et al. Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. J Immunother Cancer. 2017;5:71\u201383.","journal-title":"J Immunother Cancer"},{"key":"55_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40425-018-0337-7","volume":"6","author":"L Sun","year":"2018","unstructured":"Sun L, Funchain P, Song JM, Rayman P, Tannenbaum C, Ko J, et al. Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series. J Immunother Cancer. 2018;6:36\u201342.","journal-title":"J Immunother Cancer"},{"key":"55_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/sj.mt.6300282","volume":"16","author":"SH Hong","year":"2008","unstructured":"Hong SH, Jeong JS, Lee YJ, Jung HI, Cho KS, Kim CM, et al. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells. Mol Ther. 2008;16:74\u201380.","journal-title":"Mol Ther"},{"key":"55_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1046\/j.1440-1746.2000.02236.x","volume":"15","author":"K Suzuki","year":"2000","unstructured":"Suzuki K, Kashimura H, Ohkawa J, Itabashi M, Watanabe T, Sawahata T, et al. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J Gastroenterol Hepatol. 2000;15:744\u201351.","journal-title":"J Gastroenterol Hepatol"},{"key":"55_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0092-8674(89)90035-4","volume":"59","author":"GB Morin","year":"1989","unstructured":"Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521\u20139.","journal-title":"Cell"},{"key":"55_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.humpath.2004.07.010","volume":"35","author":"M Sabah","year":"2004","unstructured":"Sabah M, Cummins R, Leader M, Kay E. Expression of human telomerase reverse transcriptase in gastrointestinal stromal tumors occurs preferentially in malignant neoplasms. Hum Pathol. 2004;35:1231\u20135.","journal-title":"Hum Pathol"},{"key":"55_CR7","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1200\/JCO.2005.06.944","volume":"23","author":"J D\u00f4mont","year":"2005","unstructured":"D\u00f4mont J, Pawlik TM, Boige V, Rose M, Weber JC, Hoff PM, et al. Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol. 2005;23:3086\u201393.","journal-title":"J Clin Oncol"},{"key":"55_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","volume":"33","author":"JW Shay","year":"1997","unstructured":"Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787\u201391.","journal-title":"Eur J Cancer"},{"key":"55_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ymthe.2006.02.011","volume":"14","author":"EJ Small","year":"2006","unstructured":"Small EJ, Carducci MA, Burke JM, Rodriguez R, Fong L, van Ummersen L, et al. A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer. Mol Ther. 2006;14:107\u201317.","journal-title":"Mol Ther"},{"key":"55_CR10","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/sj.gt.3301424","volume":"8","author":"J Nemunaitis","year":"2001","unstructured":"Nemunaitis J, Cunningham C, Buchanan A, Blackburn A, Edelman G, Maples P, et al. Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther. 2001;8:746\u201359.","journal-title":"Gene Ther"},{"key":"55_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1158\/1078-0432.CCR-05-2038","volume":"12","author":"SA Laurie","year":"2016","unstructured":"Laurie SA, Bell JC, Atkins HL, Roach J, Bamat MK, O\u2019Neil JD, et al. A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization. Clin Cancer Res. 2016;12:2555\u201362.","journal-title":"Clin Cancer Res"},{"key":"55_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature10358","volume":"477","author":"CJ Breitbach","year":"2011","unstructured":"Breitbach CJ, J. Burke J, Jonker D, Stephenson J, Haas AR, Chow LQ, et al. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature. 2011;477:99\u2013102.","journal-title":"Nature"},{"key":"55_CR13","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1158\/1078-0432.CCR-08-0524","volume":"14","author":"L Vidal","year":"2008","unstructured":"Vidal L, Pandha HS, Yap TA, White CL, Twigger K, Vile RG, et al. A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin Cancer Res. 2008;14:7127\u201337.","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0055-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T06:19:36Z","timestamp":1659075576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0055-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":13,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1038\/s41417-018-0055-9","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}